Deployment of COVID-19 treatments for highest risk non-hospitalised patients


On 30 May 2022, the Department of Health and Social Care (DHSC) published an Independent Advisory Group report which identifies cohorts deemed to be at the highest risk of an adverse COVID outcome. The UK-wide clinical access policy for COVID-19 treatments for non-hospitalised patients has been updated to include additional groups of patients the report identifies as potentially eligible for treatment. These changes take effect from 13 June 2022.

Most patients will be contacted by a COVID-19 Medicine Delivery Unit (CMDU) following their positive registered test result to arrange assessment and treatment. However, a small proportion of patients may need to be referred by GP practices or 111. More information is outlined in this policy update and letter.